Market Sentiment Turns Risk-Off Amid Disappointing Forecasts and Supply Chain Constraints
A selloff in chip stocks, led by Advanced Micro Devices (AMD) and Super Micro Computer (SMCI), rattled investors on Wednesday as both companies reported earnings that fell short of expectations. The downturn comes after a surge in investor optimism driven by rising investments in artificial intelligence (AI) and the anticipated boost in demand for AI-related chips.
AMD’s shares plummeted by 5.4%, wiping out over $13 billion in market value, as its forecast of $4 billion in AI chip sales for 2024 failed to meet Wall Street’s high expectations. This shortfall, coupled with concerns about supply chain constraints, dampened investor sentiment towards the company.
Similarly, Super Micro Computer, which had seen its stock soar nearly 200% this year, experienced an 11% decline as its third-quarter revenue missed estimates. Questions arose regarding the profitability of its new line of servers, further contributing to the sell-off in chip stocks.
The market’s shift towards a risk-off sentiment in recent days has exacerbated the impact of earnings disappointments, according to Russell Hackmann, president of Hackmann Wealth Partners. Supply chain constraints have hindered both AMD and Super Micro Computer from fully capitalizing on the surging demand for AI equipment.
Despite the setback, analysts remain optimistic about AMD’s prospects, anticipating that easing supply chain constraints will enable the company to capture a larger share of the AI chip market and potentially generate substantial revenue. However, several analysts revised their price targets for AMD downward in response to the earnings miss, reflecting the market’s cautious outlook.
Overall, the earnings reports from AMD and Super Micro Computer underscore the challenges facing chip manufacturers amid supply chain disruptions and heightened market expectations.
You might like this article:Pfizer Reports Strong Revenue and Adjusts Profit Outlook, Driven by Cost Cuts and Non-Covid Sales